Literature DB >> 24018959

Induction of human umbilical Wharton's jelly-derived stem cells toward oligodendrocyte phenotype.

Elmira Mikaeili Agah1, Kazem Parivar, Mohammad Nabiuni, Mehrdad Hashemi, Masoud Soleimani.   

Abstract

In this study, we examined phenotypic features of human Wharton's jelly mesenchymal stem cells-derived oligodendrocytes. We induced human WJMSCs to form OLs by signaling molecules including basic fibroblastic growth factor, platelet-derived growth factor-AA, and triiodothyronine hormone. Differentiated WJMSCs showed morphologic characteristics of an OL phenotype. Expression of surface markers and genes in oligodendrocyte precursor cells or OLs were analyzed by immunocytochemistry staining and real-time polymerase chain reaction, respectively. These results suggest that WJMSCs could be programmed to OLs and might provide a potential source for cell therapy in neurodegenerative disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24018959     DOI: 10.1007/s12031-013-0094-5

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  28 in total

Review 1.  A cell-intrinsic timer that operates during oligodendrocyte development.

Authors:  B Durand; M Raff
Journal:  Bioessays       Date:  2000-01       Impact factor: 4.345

Review 2.  Defining glial cells during CNS development.

Authors:  S C Zhang
Journal:  Nat Rev Neurosci       Date:  2001-11       Impact factor: 34.870

3.  Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord.

Authors:  Hwai-Shi Wang; Shih-Chieh Hung; Shu-Tine Peng; Chun-Chieh Huang; Hung-Mu Wei; Yi-Jhih Guo; Yu-Show Fu; Mei-Chun Lai; Chin-Chang Chen
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

4.  Efficient induction of oligodendrocytes from human embryonic stem cells.

Authors:  Sang-Moon Kang; Myung Soo Cho; Hyemyung Seo; Chul Jong Yoon; Sun Kyung Oh; Young Min Choi; Dong-Wook Kim
Journal:  Stem Cells       Date:  2006-10-19       Impact factor: 6.277

5.  Induction of oligodendrocyte differentiation from adult human fibroblast-derived induced pluripotent stem cells.

Authors:  Shin-ichiro Ogawa; Yasuhito Tokumoto; Jun Miyake; Teruyuki Nagamune
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-06-22       Impact factor: 2.416

6.  Neural progenitors from human embryonic stem cells.

Authors:  B E Reubinoff; P Itsykson; T Turetsky; M F Pera; E Reinhartz; A Itzik; T Ben-Hur
Journal:  Nat Biotechnol       Date:  2001-12       Impact factor: 54.908

7.  Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease.

Authors:  Mark L Weiss; Satish Medicetty; Amber R Bledsoe; Raja Shekar Rachakatla; Michael Choi; Shosh Merchav; Yongquan Luo; Mahendra S Rao; Gopalrao Velagaleti; Deryl Troyer
Journal:  Stem Cells       Date:  2005-10-13       Impact factor: 6.277

Review 8.  Remyelinating strategies for the treatment of multiple sclerosis.

Authors:  Martin Stangel; Hans-Peter Hartung
Journal:  Prog Neurobiol       Date:  2002-12       Impact factor: 11.685

9.  Matrix cells from Wharton's jelly form neurons and glia.

Authors:  Kathy E Mitchell; Mark L Weiss; Brianna M Mitchell; Phillip Martin; Duane Davis; Lois Morales; Bryan Helwig; Mark Beerenstrauch; Khalil Abou-Easa; Tammi Hildreth; Deryl Troyer; Satish Medicetty
Journal:  Stem Cells       Date:  2003       Impact factor: 6.277

10.  Cografted Wharton's jelly cells-derived neurospheres and BDNF promote functional recovery after rat spinal cord transection.

Authors:  Liang Zhang; Hong-Tian Zhang; Sun-Quan Hong; Xu Ma; Xiao-Dan Jiang; Ru-Xiang Xu
Journal:  Neurochem Res       Date:  2009-05-22       Impact factor: 3.996

View more
  1 in total

1.  The effects of human Wharton's jelly cell transplantation on the intervertebral disc in a canine disc degeneration model.

Authors:  Yan Zhang; Hui Tao; Tao Gu; Mingyue Zhou; Zhiwei Jia; Gangqiang Jiang; Chun Chen; Zhihua Han; Cheng Xu; Deli Wang; Qing He; Dike Ruan
Journal:  Stem Cell Res Ther       Date:  2015-08-27       Impact factor: 6.832

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.